Global Follicle Stimulating Hormone Market Overview 2024, Forecast To 2033
8 Mar, 2024
The follicle stimulating hormone market (2) rose from $1.94 billion in 2023 to $2.05 billion in 2024, with a CAGR of 5.7%, driven by hormonal disorder prevalence. Expectations foresee growth to $2.49 billion by 2028, with a CAGR of 5.0%, due to therapeutic expansions and aging demographics. Trends include biosimilar advancements and regulatory approvals.
Global Follicle Stimulating Hormone Market Key Driver
The increase in the number of content creators is fueling the growth of the photo-sharing market. With over 207 million content creators in 2023, there is a significant surge in user-generated content, driving the demand for platforms to share photos.
Get A Free Sample Of The Global Follicle Stimulating Hormone Market ReportGlobal Follicle Stimulating Hormone Market Segments
The follicle stimulating hormone market covered in this report is segmented –
1) Type:Recombinant FSH, Urinary FSH
2) Application:Infertility Treatment, Assisted Reproductive Technology (ART), Other Applications
3) End-Users:Infertility Center, Hospitals, Other End-Users
By Geography: The countries covered in the follicle stimulating hormone market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
North America was the largest region in the follicle stimulating hormone market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the follicle stimulating hormone market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Follicle Stimulating Hormone Industry Players
Pfizer Inc.; Novartis AG; Abbott Laboratories; Sanofi S.A.; Boehringer Ingelheim GmbH; Merck KGaA; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Intas Pharmaceuticals Ltd.; Cipla Ltd.; Ferring Pharmaceuticals Inc.; Lupin Limited; Zydus Lifesciences Limited; Livzon Pharmaceutical Group Inc.; Emcure Pharmaceuticals Ltd.; LG Chem's life sciences; IBSA Group; Bharat Serums and Vaccines Limited; Nihon Kohden Corp.; Anhui Anke Biotechnology Group Co. Ltd.; Taj Pharmaceuticals Ltd.; Genpharm Inc.; Cadwell Laboratories Inc.; Creative BioMart; Electrical Geodesics Inc.; Lee Biosolutions Inc.; Trumac Healthcare; Midas Pharma GmbH; Biogenix Inc. Pvt. Ltd.; Shanghai Techwell Biopharmaceutical Co. Ltd.
Get The Full Global Follicle Stimulating Hormone Market Report
Follicle Stimulating Hormone Market Overview
Follicle-stimulating hormone is a hormone that the pituitary gland secretes and is involved in sexual maturation and reproduction. It has an impact on how well the testicles and ovaries work. Follicle-stimulating hormone assists in regulating both the ovaries' egg production and the menstrual cycle.